LifeVantage Corporation (LFVN)
14.42
0.17 (1.19%)
At close: Apr 15, 2025, 3:59 PM
15.15
5.06%
After-hours: Apr 15, 2025, 05:37 PM EDT
1.19% (1D)
| Bid | 12.51 |
| Market Cap | 180.99M |
| Revenue (ttm) | 212.15M |
| Net Income (ttm) | 7.34M |
| EPS (ttm) | 0.57 |
| PE Ratio (ttm) | 25.3 |
| Forward PE | 20.96 |
| Analyst | Buy |
| Ask | 15.15 |
| Volume | 94,241 |
| Avg. Volume (20D) | 237,852 |
| Open | 14.25 |
| Previous Close | 14.25 |
| Day's Range | 14.07 - 14.74 |
| 52-Week Range | 5.22 - 27.38 |
| Beta | 0.78 |
About LFVN
LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3...
Industry Packaged Foods
Sector Consumer Defensive
IPO Date Apr 7, 1994
Employees 222
Stock Exchange NASDAQ
Ticker Symbol LFVN
Website https://www.lifevantage.com
Analyst Forecast
According to 2 analyst ratings, the average rating for LFVN stock is "Buy." The 12-month stock price forecast is $30.5, which is an increase of 111.51% from the latest price.
Stock ForecastsNext Earnings Release
LifeVantage Corporation is scheduled to release its earnings on May 1, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
6 days ago
-9.67%
Shares of companies within the broader consumer st...
Unlock content with
Pro Subscription
2 months ago
-16.49%
Lifevantage shares are trading lower following Q2 financial results.
